|
Increasingly, patients with cancer are surviving their disease and are faced with significant challenges regarding quality of life. According to NIH surveys, in 2000, approximately 2.5 million adults of childbearing age were cancer survivors, and by 2010 it is estimated that 1 of every 250 adults will be survivors of childhood cancer. One significant aspect of survivability is the strong desire of patients to have a genetic family.
At UCSF, we have developed a multi-disciplinary team to move this field of clinical care and medical research forward. The depth and breadth of the Center for Reproductive Health (CRH), staffed by reproductive endocrinologists, urologists, psychologists, and genetic counselors, as well as the expertise of clinical embryologists and experts in gamete biology through the CRH and the Center for Reproductive Sciences (CRS) forms the foundation of our program.
Clinical care necessitates the immediate response of our team. All patients are seen within 24-48 hours of calling our office at . We are aware that critical clinical decisions regarding cancer treatment are made quickly and that our role is appraise patients of all available options for fertility preservation, including awareness of options should they chose to not pursue active management prior to cancer treatment. Education and counseling, alone, are valuable to the patient who should make an active decision rather than deal, in ignorance, with the consequences of their cancer therapy.
Services offered at the Center for Reproductive Health include:
- Medical Therapies
- Assisted Reproductive Technology (ART)
- Fertility Preservation Surgery
- Oocyte and Ovarian Tissue Cryopreservation
- Sperm Cryopreservation
- In Vitro Maturation (IVM)
- Urology Services
- Advanced Sperm Retrieval Services
- Pre-Implantation Genetic Diagnosis (PGD)
- Donor Egg Program
- Donor Embryo Program
- Surrogacy Services
- Mental Health Services
- Complementary and Alternative Medicine Services
Our research endeavors are broad reaching and range from surveys to assess patient attitudes and awareness of risk to fertility and how this loss would factor into their life choices, studies to evaluate markers to predict the extent of impact on ovarian aging and fertility from cancer therapies, to the development of improved interventional strategies such as new models for ovarian stimulation, in vitro oocyte maturation, new strategies for cryopreservation of gametes and ovarian tissue, and the potential generation of human primordial germ cells through stem cell technology. Initial successes in this area might broaden the target to diagnostic and therapeutic management of infertility with a wide range of etiologies.
Our Fertility Preservation Experts Include:
-
Mitchell Rosen, MD, HCLD, Director Fertility Preservation Center and Reproductive Laboratories
-
Marcelle Cedars, MD, Director, Division of Reproductive Endocrinology and Infertility and Center for Reproductive Health
-
Shehua Shen, MD, Director Embryology Laboratories, Fertility Preservation Specialist
-
Xinli Yang, PhD, Senior Embryologist, Specialist in Fertility Preservation Techniques
-
Marco Conti, MD, PhD, Director of Center for Reproductive Science, Gamete Biologist (Oocyte)
-
Robert Blelloch, MD, PhD, Gamete Biologist (Sperm)
- Diana Laird, PhD
- Miguel Ramalho-Santos, PhD
-
Laurie Pasch, PhD, Psychologist
-
Gina Davis, Genetic Counselor
-
Audra Katz, RN, Nurse Coordinator
-
Dennis Troyer, RN, Nurse Coordinator, Urology
-
Mindy Goldman, MD Specialist in Women’s Health and Gynecological Issues
To schedule an appointment to meet with a physician please call
-
Rosemary Benson, Patient Coordinator
|
|